STAT

Debate over whether to test a second Ebola vaccine turns acrimonious

An aggressive push to use a second experimental Ebola vaccine to try to help stop the outbreak in the Democratic Republic of the Congo may have backfired.
The DRC's health minister, Dr. Oly Ilunga Kalenga, seen visiting an Ebola treatment center in March. Source: JOHN WESSELS/AFP/Getty Images

An aggressive push to use a second experimental Ebola vaccine to try to help stop the nearly yearlong outbreak in the Democratic Republic of the Congo may have backfired, with the DRC’s health minister insisting the country will not allow use of the vaccine, made by pharmaceutical giant Johnson & Johnson.

The health minister, Dr. Oly Ilunga, had previously suggested a consortium made up of the London School of Hygiene and Tropical Medicine, Doctors Without Borders, and others might be permitted to conduct a clinical trial of J&J’s Ebola vaccine in the country, although not in the outbreak zone, where Merck’s experimental vaccine is being used.

Late last week he rescinded that option, saying the country would not approve a trial of another experimental vaccine during the ongoing outbreak, which has infected

You're reading a preview, sign up to read more.

More from STAT

STAT2 min read
Purdue Pharma, Maker Of OxyContin And Other Drugs, Files For Bankruptcy
Facing thousands of lawsuits alleging that it helped spark the opioid addiction crisis, privately held Purdue Pharma announced it had filed for bankruptcy,
STAT3 min readSociety
Opinion: A Dangerous View: Why It’s A Mistake For Medical Schools To Ignore Social Justice
An op-ed in the Wall Street Journal called for getting back to basics in medical school and forgoing teaching on gun violence or other social issues. The author has it…
STAT7 min read
Could Editing The DNA Of Embryos With CRISPR Help Save People Who Are Already Alive?
There is a little-discussed potential application of CRISPR: tweaking its DNA of embryos to help save someone who is already alive.